{"fr":{"SDG_GOAL":"Objectif 3. Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge","SDG_TARGET":"3.b Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments","SDG_INDICATOR":"3.b.2.Montant total net de l\u2019aide publique au d\u00e9veloppement consacr\u00e9 \u00e0 la recherche m\u00e9dicale et aux soins de sant\u00e9 de base","STAT_CONC_DEF":"C'est la proportion des d\u00e9penses publiques allou\u00e9es \u00e0 la recherche en sante aux d\u00e9penses totales publiques de la sant\u00e9.","DATA_COMP":"Rapport entre les  d\u00e9penses publiques allou\u00e9es \u00e0 la recherche en sante et les  d\u00e9penses totales publiques de la sant\u00e9, exprim\u00e9 en pourcentage.","COVERAGE":"Non disponible"},"SDG_GOAL":"Goal 3. Ensure healthy lives and promote well-being for all at all ages","SDG_TARGET":"3.b Support research and development of vaccines and drugs against diseases, communicable or not, which mainly affect the inhabitants of developing countries, provide affordable access to essential drugs and vaccines, in accordance with the Declaration Doha Round of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and Public Health, which reaffirms the right of developing countries to take full advantage of the flexibility provisions of this agreement when it comes to protecting public health and, in particular, ensuring universal access to medicines","SDG_INDICATOR":"3.b.2. Total net amount of official development assistance devoted to medical research and basic health care","STAT_CONC_DEF":"It is the proportion of public expenditure allocated to health research to total public expenditure on health.","DATA_COMP":"Ratio of public spending on health research to total public spending on health, expressed as a percentage.","COVERAGE":"Not available","indicator":"3.b.2","target_id":"3.b","sdg_goal":"3","reporting_status":"complete","data_non_statistical":false,"graph_type":"line","indicator_sort_order":"03-0b-02","indicator_name":"Proportion d\u2019indicateurs du d\u00e9veloppement durable \u00e9tablis \u00e0 l\u2019\u00e9chelle nationale, ventil\u00e9s de mani\u00e8re exhaustive en fonction de la cible conform\u00e9ment aux Principes fondamentaux de la statistique officielle","graph_title":"Proportion d\u2019indicateurs du d\u00e9veloppement durable \u00e9tablis \u00e0 l\u2019\u00e9chelle nationale, ventil\u00e9s de mani\u00e8re exhaustive en fonction de la cible conform\u00e9ment aux Principes fondamentaux de la statistique officielle"}